Relative Performance of Common Biochemical Indicators in Detecting Cigarette Smoking
Overview
Authors
Affiliations
Aims: Many cities have banned indoor smoking in public places. Thus, an updated recommendation for a breath carbon monoxide (CO) cut-off is needed that optimally determines smoking status. We evaluated and compared the performance of breath CO and semiquantitative cotinine immunoassay test strips (urine and saliva NicAlert®) alone and in combination.
Design: Cross-sectional study.
Setting: Urban drug addiction research and treatment facility.
Participants: Ninety non-treatment-seeking smokers and 82 non-smokers.
Measurements: Participants completed smoking histories and provided breath CO, urine and saliva specimens. Urine and saliva specimens were assayed for cotinine by NicAlert® and liquid chromatography-tandem mass spectrometry (LCMSMS).
Findings: An optimal breath CO cut-off was established using self-report and LCMSMS analysis of cotinine, an objective indicator, as reference measures. Performance of smoking indicators and combinations were compared to the reference measures. Breath CO ≥5 parts per million (p.p.m.) optimally discriminated smokers from non-smokers. Saliva NicAlert® performance was less effective than the other indicators.
Conclusions: In surveys of smokers and non-smokers in areas with strong smoke-free laws, the breath carbon monoxide cut-off that discriminates most effectively appears to be ≥5 p.p.m. rather than the ≥10 p.p.m. cut-off often used. These findings may not generalize to clinical trials, regions with different carbon monoxide pollution levels or areas with less stringent smoke-free laws.
Coleman S, Higgins S, Smyth J, Rodriguez B, Loganathan M, Gaalema D Exp Clin Psychopharmacol. 2023; 32(3):270-276.
PMID: 37602999 PMC: 10879453. DOI: 10.1037/pha0000677.
Nollen N, Ahluwalia J, Mayo M, Ellerbeck E, Leavens E, Salzman G JAMA Netw Open. 2023; 6(6):e2317895.
PMID: 37338906 PMC: 10282892. DOI: 10.1001/jamanetworkopen.2023.17895.
Nollen N, Cox L, Mayo M, Ellerbeck E, Arnold M, Salzman G Contemp Clin Trials Commun. 2022; 30:101032.
PMID: 36387983 PMC: 9641174. DOI: 10.1016/j.conctc.2022.101032.
Kim S, Kim S, Gona P J Smok Cessat. 2021; 2021:6678237.
PMID: 34306232 PMC: 8279201. DOI: 10.1155/2021/6678237.
Ray L, Green R, Enders C, Leventhal A, Grodin E, Li G Am J Psychiatry. 2021; 178(9):818-828.
PMID: 34080890 PMC: 8999864. DOI: 10.1176/appi.ajp.2020.20070993.